These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 781579)

  • 1. BCG immunotherapy of a mucous membrane malignant melanoma. Report of a case.
    Pliskin ME; Mastrangelo MJ; Bellet R; Berkelhammer J
    Oral Surg Oral Med Oral Pathol; 1976 Jul; 42(1):73-9. PubMed ID: 781579
    [No Abstract]   [Full Text] [Related]  

  • 2. [Multidisciplinary treatment of malignant melanoma of the nose and paranasal sinuses--with special reference to oral administration of enterosoluble BCG capsules].
    Saito H; Hozawa J; Takagi A; Fukuoka K; Nozawa I; Kamimura T
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1555-61. PubMed ID: 6191718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [BCG immunotherapy for malignant melanoma of the nose and paranasal sinuses (author's transl)].
    Saito H; Hozawa J; Kasahara M; Takagi A; Nagai M
    Nihon Jibiinkoka Gakkai Kaiho; 1980 Jun; 83(6):647-53. PubMed ID: 7463195
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunoprophylaxis of malignant melanoma with systemic BCG: study of strain, dose, and schedule.
    Gutterman JU; Mavligit G; McBride C; Frei E; Hersh EM
    Natl Cancer Inst Monogr; 1973 Dec; 39():205-12. PubMed ID: 4595319
    [No Abstract]   [Full Text] [Related]  

  • 5. Mucosal melanoma. Immunological findings in a rare case treated with BCG vaccine, autologous tumor cells, and cytarabine.
    Edström S; Jacobsson S; Jeppsson PH
    Arch Otolaryngol; 1979 Jan; 105(1):48-50. PubMed ID: 760707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of melanoma of nose and paranasal sinuses.
    Walker EA; Snow JB
    Arch Otolaryngol; 1969 Apr; 89(4):652-60. PubMed ID: 5766758
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunotherapy of human malignant melanoma with oil-attached BCG cell-wall skeleton.
    Yamamura Y; Yoshizaki K; Azuma I; Yagura T; Watanabe T
    Gan; 1975 Aug; 66(4):355-63. PubMed ID: 1102379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of administering B.C.G. to patients with melanoma.
    Grant RM; Mackie R; Cochran AJ; Murray EL; Hoyle D; Ross C
    Lancet; 1974 Nov; 2(7889):1096-100. PubMed ID: 4139404
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro monitoring of cellular function during BCG immunotherapy.
    Golub SH; Roth JA; Forsythe A; Morton DL
    Bibl Haematol; 1975 Oct; (43):270-3. PubMed ID: 786261
    [No Abstract]   [Full Text] [Related]  

  • 10. Malignant melanoma.
    Spitler LE
    J Invest Dermatol; 1976 Sep; 67(3):435-41. PubMed ID: 787436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and histologic correlation of melanoma regression after intralesional BCG therapy: a case report.
    Mastrangelo MJ; Kim YH; Bornstein RS; Chee DO; Sulit HL; Yarbro JW; Prehn RT
    J Natl Cancer Inst; 1974 Jan; 52(1):19-24. PubMed ID: 4590009
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mucous nasosinus melanoma. Apropos of a case].
    Medina Banegas A; Osete Albaladejo JM; González Ortin M; Martínez Silla G; Arcas Martínez-Jalos I
    Acta Otorrinolaringol Esp; 1989; 40(5):365-7. PubMed ID: 2631901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of sinonasal melanoma: clinical experience and review of the literature.
    Roth TN; Gengler C; Huber GF; Holzmann D
    Head Neck; 2010 Oct; 32(10):1385-92. PubMed ID: 20146340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report.
    Nathanson L; Clark DA
    Natl Cancer Inst Monogr; 1973 Dec; 39():221-4. PubMed ID: 4595321
    [No Abstract]   [Full Text] [Related]  

  • 15. Melanoma of the nasal and paranasal sinus mucosa.
    Trapp TK; Fu YS; Calcaterra TC
    Arch Otolaryngol Head Neck Surg; 1987 Oct; 113(10):1086-9. PubMed ID: 3620131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Case of a rare primary ectopic meningioma of the nose and maxillary sinus in a child].
    Stanisavljevic B; Stefanovic P; Pejcic M; Djordjevic M
    Rev Laryngol Otol Rhinol (Bord); 1975; 96(1-2):81-4. PubMed ID: 1144963
    [No Abstract]   [Full Text] [Related]  

  • 17. Specific cytotoxic antibody in the sera of patients with melanoma.
    Kilpatrick RJ; Seigler HF
    J Surg Res; 1976 Nov; 21(5):301-5. PubMed ID: 794584
    [No Abstract]   [Full Text] [Related]  

  • 18. Experience with BCG adjuvant immunotherapy in stage II malignant melanoma.
    Peter HH; Deutschmann EM; Schultheis W; Deicher H
    Dev Biol Stand; 1977 Apr 13-15; 38():537-40. PubMed ID: 344106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Malignant melanomas of the nasal cavity and paranasal sinuses].
    Dreher A; Grevers G
    Laryngorhinootologie; 1995 Feb; 74(2):95-7. PubMed ID: 7710613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal melanomas of the head and neck.
    Snow GB; van der Waal I
    Otolaryngol Clin North Am; 1986 Aug; 19(3):537-47. PubMed ID: 3748582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.